|
|
||||||||
Journal of Lipid Research, Vol 30, 1397-1403, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
M Sorci-Thomas, MM Prack, N Dashti, F Johnson, LL Rudel and DL Williams
Department of Pharmacological Sciences, State University of New York, Stony Brook, NY 11794-8651.
Isocaloric substitution of polyunsaturated fat for saturated fat reduces concentrations of total plasma cholesterol and high density lipoproteins (HDL) in nonhuman primates. The biochemical mechanisms through which polyunsaturated fat lowers plasma HDL concentrations are not well understood but must involve changes in HDL production or HDL clearance from plasma, or both. To determine whether dietary polyunsaturated fat (P/S = 2.2) alters apolipoprotein (apo) A-I production, African green monkeys (Cercopithecus aethiops) were fed diets containing polyunsaturated fat or saturated fat (P/S = 0.3) each in combination with high (0.8 mg/kcal) and low (0.03 mg/kcal) amounts of dietary cholesterol. Animals fed polyunsaturated fat at either cholesterol level had lower plasma concentrations of total cholesterol and HDL cholesterol. Plasma apoA-I concentration was reduced by 16% by polyunsaturated fat in the high cholesterol group. The rate of hepatic apoA-I secretion, as estimated by the accumulation of perfusate apoA-I during recirculating liver perfusion, was reduced by 19% in animals consuming the high cholesterol, polyunsaturated fat diet. Hepatic apoA- I mRNA concentrations, as measured by DNA-excess solution hybridization, also were reduced by 22% in the high cholesterol, polyunsaturated fat-fed animals. In contrast, intestinal apoA-I mRNA concentrations were not altered by the type of dietary fat. Plasma apoA- II and hepatic apoA-II mRNA concentrations also were not altered by the type of dietary fat. These data indicate that dietary polyunsaturated fat can selectively alter the expression of the apoA-I gene in a tissue- specific manner.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
H. Mezdour, G. Larigauderie, G. Castro, G. Torpier, J. Fruchart, M. Nowak, J.-C. Fruchart, M. Rouis, and N. Maeda Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency J. Lipid Res., May 1, 2006; 47(5): 912 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Mooradian, M. J. Haas, and N. C. W. Wong The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels Endocr. Rev., February 1, 2006; 27(1): 2 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokoyama Assembly of High-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dashti, Q. Feng, M. R. Freeman, M. Gandhi, and F. A. Franklin Trans Polyunsaturated Fatty Acids Have More Adverse Effects than Saturated Fatty Acids on the Concentration and Composition of Lipoproteins Secreted by Human Hepatoma HepG2 Cells J. Nutr., September 1, 2002; 132(9): 2651 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Huggins, E. R. Burleson, J. K. Sawyer, K. Kelly, L. L. Rudel, and J. S. Parks Determination of the tissue sites responsible for the catabolism of large high density lipoprotein in the African green monkey J. Lipid Res., March 1, 2000; 41(3): 384 - 394. [Abstract] [Full Text] |
||||
![]() |
L. Calleja, M. A. Paris, A. Paul, E. Vilella, J. Joven, A. Jimenez, G. Beltran, M. Uceda, N. Maeda, and J. Osada Low-Cholesterol and High-Fat Diets Reduce Atherosclerotic Lesion Development in ApoE-Knockout Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2368 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Velez-Carrasco, A. H. Lichtenstein, F. K. Welty, Z. Li, S. Lamon-Fava, G. G. Dolnikowski, and E. J. Schaefer Dietary Restriction of Saturated Fat and Cholesterol Decreases HDL ApoA-I Secretion Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 918 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. J. Wu, S. K. Reaves, Y. R. Wang, Y. Wu, P. P. Lei, and K. Y. Lei Zinc deficiency decreases plasma level and hepatic mRNA abundance of apolipoprotein A-I in rats and hamsters Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1516 - C1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, M. J. Evans, M. S. Scicchitano, R. A. Bhat, and S. K. Karathanasis Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing J. Biol. Chem., April 10, 1998; 273(15): 9270 - 9278. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kilbourne, R. Widom, D. C. Harnish, S. Malik, and S. K. Karathanasis Involvement of Early Growth Response Factor Egr-1 in Apolipoprotein AI Gene Transcription J. Biol. Chem., March 24, 1995; 270(12): 7004 - 7010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ladias and S. Karathanasis Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily Science, February 1, 1991; 251(4993): 561 - 565. [Abstract] [PDF] |
||||
![]() |
J. Dallongeville, E. Bauge, A. Tailleux, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, and B. Staels Peroxisome Proliferator-activated Receptor alpha Is Not Rate-limiting for the Lipoprotein-lowering Action of Fish Oil J. Biol. Chem., February 9, 2001; 276(7): 4634 - 4639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |